We are live on ! Find out more
SGC

Slocum, Gordon & Co Portfolio holdings

AUM $151M
1-Year Est. Return 26.83%
This Fund
S&P 500
This Quarter Est. Return
+2.7%
1 Year Est. Return
+26.83%
3 Year Est. Return
+55.15%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$138M
AUM Growth
+$17.3M
Cap. Flow
+$350K
Cap. Flow %
0.25%
Top 10 Hldgs %
63.31%
Holding
162
New
19
Increased
16
Reduced
30
Closed
39

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.73M
2
JPM icon
JPMorgan Chase
JPM
+$194K
3
DVN icon
Devon Energy
DVN
+$151K
4
XOM icon
ExxonMobil
XOM
+$125K
5
AMZN icon
Amazon
AMZN
+$113K

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$383K
2
TRV icon
Travelers Companies
TRV
+$214K
3
JNJ icon
Johnson & Johnson
JNJ
+$210K
4
PG icon
Procter & Gamble
PG
+$195K
5
PFE icon
Pfizer
PFE
+$185K

Sector Composition

Rank Sector Weight
1 Healthcare 27.41%
2 Utilities 20.58%
3 Technology 15.96%
4 Consumer Staples 11.59%
5 Energy 8.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WBA
26
DELISTED
Walgreens Boots Alliance
WBA
$1.1M 0.8%
38,759
-394
-1% -$12.8K
UNP icon
27
Union Pacific
UNP
$172B
$923K 0.67%
4,509
– –
DD icon
28
DuPont de Nemours
DD
$18.7B
$851K 0.62%
9,495
– –
DOW icon
29
Dow Inc
DOW
$21.7B
$684K 0.5%
12,842
– –
CAT icon
30
Caterpillar
CAT
$373B
$615K 0.45%
2,500
– –
HD icon
31
Home Depot
HD
$332B
$585K 0.42%
1,883
+35
+2% +$10.3K
WMT icon
32
Walmart Inc
WMT
$884B
$565K 0.41%
10,785
– –
GIS icon
33
General Mills
GIS
$19.4B
$552K 0.4%
7,200
– –
ABT icon
34
Abbott
ABT
$183B
$512K 0.37%
4,700
– –
PEP icon
35
PepsiCo
PEP
$191B
$440K 0.32%
2,376
– –
VOD icon
36
Vodafone
VOD
$37.2B
$412K 0.3%
43,557
– –
BRK.B icon
37
Berkshire Hathaway Class B
BRK.B
$1.1T
$367K 0.27%
1,077
-1
-0.1% -$326
RVTY icon
38
Revvity
RVTY
$12.7B
$350K 0.25%
2,950
– –
CL icon
39
Colgate-Palmolive
CL
$73.3B
$343K 0.25%
4,446
– –
ZTS icon
40
Zoetis
ZTS
$31.9B
$334K 0.24%
1,942
– –
GEHC icon
41
GE HealthCare
GEHC
$31.6B
$298K 0.22%
3,670
-154
-4% -$12.3K
BAX icon
42
Baxter International
BAX
$13.8B
$296K 0.22%
6,505
-150
-2% -$6.53K
ETN icon
43
Eaton
ETN
$150B
$254K 0.18%
1,265
– –
AMGN icon
44
Amgen
AMGN
$209B
$250K 0.18%
1,125
+63
+6% +$14.6K
BMY icon
45
Bristol-Myers Squibb
BMY
$132B
$236K 0.17%
3,694
+190
+5% +$12.7K
AMZN icon
46
Amazon
AMZN
$2.53T
$223K 0.16%
1,711
+991
+138% +$113K
NSC icon
47
Norfolk Southern
NSC
$75B
$223K 0.16%
982
– –
CVX icon
48
Chevron
CVX
$383B
$212K 0.15%
1,347
– –
IVV icon
49
iShares Core S&P 500 ETF
IVV
$872B
$211K 0.15%
474
– –
BRKL
50
DELISTED
Brookline Bancorp
BRKL
$202K 0.15%
23,087
– –
1
2
3 4 5

Similar funds

LM
Lansing Management New York $151M AUM 13.85% 1-Year Est. Return
CAM
Crown Advisors Management Larkspur, California $151M AUM 73.11% 1-Year Est. Return
FC
FACT Capital New York $150M AUM 53.4% 1-Year Est. Return
JIM
JCP Investment Management Houston, Texas $150M AUM 19.22% 1-Year Est. Return
WBCM
Wilson & Boucher Capital Management Moraga, California $151M AUM 18.75% 1-Year Est. Return
BDS
Banco de Sabadell Miami, Florida $151M AUM 22.94% 1-Year Est. Return
CCM
Crew Capital Management Cincinnati, Ohio $151M AUM 20.49% 1-Year Est. Return
SHF
Stage Harbor Financial Westwood, Massachusetts $151M AUM 15.9% 1-Year Est. Return

Slocum, Gordon & Co's Q2 2023 Portfolio in Review

As of Q2 2023, Slocum, Gordon & Co held 162 positions worth $138M, up 14% from $121M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Slocum, Gordon & Co's Q2 2023 filing shows 19 new, 16 increased, 30 reduced and 39 closed positions. Its largest new stake was Apple: 9,936 shares worth $19.2M. The largest sale was Thermo Fisher Scientific, an estimated $383K.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 32% a quarter earlier, followed by Utilities and Technology.

  • Slocum, Gordon & Co's largest Q2 2023 buy was Apple: 9,936 shares worth $19.2M.
  • Slocum, Gordon & Co added most to JPMorgan Chase in Q2 2023, an estimated $194K increase.
  • Slocum, Gordon & Co's biggest Q2 2023 reduction was Johnson & Johnson, cutting an estimated $210K.
  • Slocum, Gordon & Co fully exited Thermo Fisher Scientific in Q2 2023, selling an estimated $383K.
  • Slocum, Gordon & Co's ten largest holdings make up 63% of its $138M portfolio in Q2 2023.
  • Slocum, Gordon & Co opened 19 new positions and closed 39 in Q2 2023.
  • Slocum, Gordon & Co's portfolio value rose 14% quarter-over-quarter to $138M.

Based on Slocum, Gordon & Co's 13F filing for Q2 2023, filed 23 Oct 2023.